Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.

about

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.

Item

http://www.wikidata.org/entity/Q47123483

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Mini-review on initiatives to ...... uclein in Parkinson's disease.

@en

Mini-review on initiatives to ...... uclein in Parkinson's disease.

@nl

type

Item

label

Mini-review on initiatives to ...... uclein in Parkinson's disease.

@en

Mini-review on initiatives to ...... uclein in Parkinson's disease.

@nl

prefLabel

Mini-review on initiatives to ...... uclein in Parkinson's disease.

@en

Mini-review on initiatives to ...... uclein in Parkinson's disease.

@nl

P1476

Mini-review on initiatives to ...... nuclein in Parkinson's disease

@en

P2093

Daniel Kam Yin Chan

http://www.w3.org/2001/XMLSchema#string

George D Mellick

http://www.w3.org/2001/XMLSchema#string

Luke Kar Man Chan

http://www.w3.org/2001/XMLSchema#string

Ying Hua Xu

http://www.w3.org/2001/XMLSchema#string

P2860

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)

Alpha-synuclein biology in Lewy body diseases

Staging of brain pathology related to sporadic Parkinson's disease

Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

Lysosomal degradation of alpha-synuclein in vivo.

P2888

s40035-017-0104-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S40035-017-0104-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nady Braidy

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099723847

http://www.w3.org/2001/XMLSchema#string

P698

29270291

http://www.w3.org/2001/XMLSchema#string

P921

Synuclein

P932

5738184

http://www.w3.org/2001/XMLSchema#string